Peloton Wealth Strategists decreased its holdings in shares of WestRock (NYSE:WRK – Get Rating) by 8.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 92,375 shares of the basic materials company’s stock after selling 8,700 shares during the quarter. […]
Peloton Wealth Strategists bought a new stake in iShares iBonds 2024 Term High Yield and Income ETF (BATS:IBHD – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 28,010 shares of the company’s stock, valued at approximately $636,000. A number of other […]
Peloton Wealth Strategists boosted its stake in iShares iBonds Dec 2029 Term Corporate ETF (NYSEARCA:IBDU – Get Rating) by 58.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 124,700 shares of the company’s stock after acquiring an additional 46,000 shares during […]
Peloton Wealth Strategists grew its stake in shares of Medtronic plc (NYSE:MDT – Get Rating) by 1.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,300 shares of the medical technology company’s stock after buying an additional 400 shares during the […]
Peloton Wealth Strategists decreased its stake in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 3.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,705 shares of the company’s stock after selling 1,600 shares during the quarter. AbbVie comprises 3.4% of […]